Jazz Pharmaceuticals plc — Director's Dealing 2021

Aug 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2021-08-05

Reporting Person: COZADD BRUCE C (Director, Chairman & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-05	Ordinary Shares	M	2652	$46.83	Acquired	309790	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-05	Incentive Stock Option (right to buy)	$46.83	M	2652	Disposed	2022-08-08	Ordinary Shares (2652)	Direct

Footnotes

F1: This option was granted pursuant to the Issuer's 2007 Equity Incentive Plan and
vested over three years from the grant date, August 9, 2012, with 1/3 vesting on the first anniversary of the grant date and the remainder vested in 24 equal monthly
installments thereafter.